Fernando Salvador

Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease

Israel Molina, Jordi Gómez i Prat, Fernando Salvador et al. · New England Journal of Medicine · 2014 · 615 citations · Full text

Toxic Profile of Benznidazole in Patients with Chronic Chagas Disease: Risk Factors and Comparison of the Product from Two Different Manufacturers

Israel Molina, Fernando Salvador, Adrián Sánchez‐Montalvá et al. · Antimicrobial Agents and Chemotherapy · 2015 · 100 citations · Full text

Pathology, Pharmacotherapy, Roche Product +18

Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

Belén Gutiérrez‐Gutiérrez, María Dolores del Toro, Alberto M. Borobia et al. · The Lancet Infectious Diseases · 2021 · 98 citations · Full text

Prognostic Evaluation, Disease Progression, Multicentre Cohort Study +11

Trypanosoma cruzi infection in a non-endemic country: epidemiological and clinical profile

Fernando Salvador, B. Trevióo, Elena Sulleiro et al. · Clinical Microbiology and Infection · 2013 · 71 citations

Parasitic Disease, Parasitic Protozoa, African Trypanosomiasis +5

Prevalence and molecular characterization of Strongyloides stercoralis, Giardia duodenalis, Cryptosporidium spp., and Blastocystis spp. isolates in school children in Cubal, Western Angola

Elena Dacal, José María Saugar, Aida de Lucio et al. · Parasites & Vectors · 2018 · 61 citations · Full text